Literature DB >> 11322834

Scatter factors and invasive growth.

P M Comoglio1, C Boccaccio.   

Abstract

Scatter factors are unequivocal signals governing a genetic program that includes cell detachment, repulsion, protection from apoptosis, invasiveness of extracellular matrices and proliferation. This pleiomorphic response is defined as 'invasive growth'. Under physiological conditions, it leads to morphogenic cell movements through the matrix, and--primarily--to ordered building of epithelial tubules. Dysfunctions in invasive growth cause enhanced proliferation, uncontrolled migration into surrounding tissues, and failure to differentiate, events that foster tumour growth and invasiveness. Scatter factors act through tyrosine kinase receptors that belong to the Met oncogene family. Here we discuss how alterations of these receptors or of their signal transduction pathways are responsible for cancer onset and progression towards metastasis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322834     DOI: 10.1006/scbi.2000.0366

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  31 in total

Review 1.  Invasive growth: from development to metastasis.

Authors:  Paolo M Comoglio; Livio Trusolino
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

3.  Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.

Authors:  Sandra S McAllister; Michelle Becker-Hapak; Giuseppe Pintucci; Michele Pagano; Steven F Dowdy
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.

Authors:  Kyung Hee Lee; Eun Young Choi; Sung Ae Koh; Min Kyoung Kim; Kyeong Ok Kim; Si Hyung Lee; Byung Ik Jang; Se Won Kim; Sang Woon Kim; Sun Kyo Song; Joon Hyuk Choi; Jae-Ryong Kim
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

5.  Endosomal dynamics of Met determine signaling output.

Authors:  Dean E Hammond; Stephanie Carter; John McCullough; Sylvie Urbé; George Vande Woude; Michael J Clague
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

6.  89Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection.

Authors:  Eric W Price; Kathryn E Carnazza; Sean D Carlin; Andrew Cho; Kimberly J Edwards; Kuntal K Sevak; Jonathan M Glaser; Elisa de Stanchina; Yelena Y Janjigian; Jason S Lewis
Journal:  J Nucl Med       Date:  2017-03-09       Impact factor: 10.057

7.  The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.

Authors:  Benedetta Peruzzi; Gagani Athauda; Donald P Bottaro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

Review 8.  MET as a target for treatment of chest tumors.

Authors:  Nicole A Cipriani; Oyewale O Abidoye; Everett Vokes; Ravi Salgia
Journal:  Lung Cancer       Date:  2008-07-30       Impact factor: 5.705

9.  First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors.

Authors:  Vicki L Keedy; Heinz-Josef Lenz; Leonard Saltz; Jennifer G Whisenant; Jordan D Berlin; Luis H Camacho
Journal:  Invest New Drugs       Date:  2018-01-29       Impact factor: 3.850

10.  3,3'-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells.

Authors:  Holly L Nicastro; Gary L Firestone; Leonard F Bjeldanes
Journal:  J Nutr Biochem       Date:  2013-08-19       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.